Join us as we discuss the data surrounding newly approved
antifungal agent, rezafungin. Interested in learning more? Join our
CE on rezafungin on July 27th at 12:00 PM EST - open to all
pharmacists!
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.